Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes

Autor: Juntima Sritabal, Srisuda Keayarsa, Nattaporn Piaraksa, Arjen M. Dondorp, Rachanee Udomsangpetch, Chirapong Utaisin, Nicholas P. J. Day, Patima Sila, Kesinee Chotivanich, Prakaykaew Charunwatthana, Somporn Saiwaew, Nicholas J. White, Ronnatrai Ruengweerayut, Sue J. Lee, Anna Leitgeb, Rangsan Niramis, Emsri Pongponratn, Mats Wahlgren, Sasithon Pukrittayakamee
Přispěvatelé: Craig, A
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Plasmodium
Erythrocytes
Physiology
Heparin
Cell
lcsh:Medicine
Epithelium
Animal Cells
Interquartile range
Red Blood Cells
Medicine and Health Sciences
Medicine
Malaria
Falciparum

lcsh:Science
Cells
Cultured

Protozoans
Multidisciplinary
biology
Malarial Parasites
Drugs
Middle Aged
Parasitic diseases
Body Fluids
3. Good health
Blood
medicine.anatomical_structure
Rosette formation
Female
Cellular Types
Anatomy
Research Article
medicine.drug
Adult
Rosette Formation
Adolescent
Plasmodium falciparum
Endothelial cells
Blood groups
Microbiology
03 medical and health sciences
Parasite Groups
parasitic diseases
Cell Adhesion
Humans
Trophozoites
Aged
Pharmacology
Blood Cells
business.industry
lcsh:R
Organisms
Endothelial Cells
Biology and Life Sciences
Epithelial Cells
Cell Biology
Tropical Diseases
biology.organism_classification
medicine.disease
Parasitic Protozoans
Malaria
Biological Tissue
030104 developmental biology
Adjunctive treatment
Parasitology
lcsh:Q
Malarial parasites
business
Apicomplexa
Blood Groups
Red blood cells
Zdroj: PLoS ONE, Vol 12, Iss 3, p e0172718 (2017)
PLoS ONE
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0172718
Popis: In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette formation) contribute to microcirculatory flow obstruction in vital organs. Heparin can reverse the underlying ligand-receptor interactions, but may increase the bleeding risks. As a heparin-derived polysaccharide, sevuparin has been designed to retain anti-adhesive properties, while the antithrombin-binding domains have been eliminated, substantially diminishing its anticoagulant activity. Sevuparin has been evaluated recently in patients with uncomplicated falciparum malaria, and is currently investigated in a clinical trial for sickle cell disease. The effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum isolates from Thailand were investigated. Trophozoite stages of P. falciparum-infected RBCs (Pf-iRBCs) were cultured from 49 patients with malaria. Pf-iRBCs were treated with sevuparin at 37°C and assessed in rosetting and in cytoadhesion assays with human dermal microvascular endothelial cells (HDMECs) under static and flow conditions. The proportion of Pf-iRBCs forming rosettes ranged from 6.5% to 26.0% (median = 12.2%). Rosetting was dose dependently disrupted by sevuparin (50% disruption by 250 μg/mL). Overall 57% of P. falciparum isolates bound to HDMECs under static conditions; median (interquartile range) Pf-iRBC binding was 8.5 (3.0-38.0) Pf-iRBCs/1000 HDMECs. Sevuparin in concentrations ≥ 100 μg/mL inhibited cytoadherence. Sevuparin disrupts P. falciparum rosette formation in a dose dependent manner and inhibits cytoadherence to endothelial cells. The data support assessment of sevuparin as an adjunctive treatment to the standard therapy in severe falciparum malaria.
Databáze: OpenAIRE